Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Scynexis completes follow-on

    Scynexis Inc. (NASDAQ:SCYX), Research Triangle Park, N.C. Business: Infectious, Ophthalmic Date completed: 2016-06-21 Type: Follow-on Raised: $22.5 million Shares: 9.4 million Price: $2.40 Shares after offering: 23.3 …

    Published on 6/27/2016
  • Selecta completes IPO

    Selecta Biosciences Inc. (NASDAQ:SELB), Watertown, Mass. Business: Drug delivery, Endocrine/Metabolic, Hematology Date completed: 2016-06-21 Type: IPO Raised: $70 million Shares: 5 million Price: $14 Shares after …

    Published on 6/27/2016
  • VBI Vaccines completes private placement

    VBI Vaccines Inc. (NASDAQ:VBIV; TSX:VBV), Cambridge, Mass. Business: Infectious Date completed: 2016-06-21 Type: Private placement Raised: $13.6 million Shares: 3.3 million Price: $4.16 Shares after offering: 36 million…

    Published on 6/27/2016
  • Verona Pharma completes private placement of units

    Verona Pharma plc (LSE:VRP; Xetra:I9S), London, U.K. Business: Inflammation, Pulmonary Date completed: 2016-06-17 Type: Private placement of units Raised: L44.7 million ($65.2 million) Units: 1.6 billion Price: 2.87p (…

    Published on 6/27/2016
  • CRISPR Therapeutics financial update

    CRISPR Therapeutics AG, Basel, Switzerland Business: Gene/Cell therapy, Hematology, Pulmonary Date announced: 2016-06-24 Note: CRISPR Therapeutics raised $38 million in a final close of a series B round, bringing the …

    Published on 6/27/2016
  • EpiBiome financial update

    EpiBiome Inc., South San Francisco, Calif. Business: Infectious Date announced: 2016-06-23 Note: EpiBiome secured a $1 million loan from Silicon Valley Bank. The company declined to disclose the terms of the loan.

    Published on 6/27/2016
  • Shenzhen Hepalink Pharmaceutical financial update

    Shenzhen Hepalink Pharmaceutical Co. Ltd. (SZSE:002399), Shenzhen, China Business: Supply/Service, Cardiovascular, Endocrine/Metabolic Date announced: 2016-06-20 Note: Shenzhen Hepalink Pharmaceutical invested $60 …

    Published on 6/27/2016
  • Spark Therapeutics financial update

    Spark Therapeutics Inc. (NASDAQ:ONCE), Philadelphia, Pa. Business: Gene/Cell therapy, Ophthalmic, Hematology Date announced: 2016-06-20 Note: Spark raised $23.6 million through the sale of 525,000 shares at $45 to cover…

    Published on 6/27/2016
  • Viking Therapeutics financial update

    Viking Therapeutics Inc. (NASDAQ:VKTX), San Diego, Calif. Business: Endocrine/Metabolic, Hematology, Musculoskeletal Date announced: 2016-06-20 Note: Viking established an at-the-market program to sell up to 3.7 million…

    Published on 6/27/2016
  • Epistem proposes placing

    Epistem Holdings plc (LSE:EHP), Manchester, U.K. Business: Diagnostic, Supply/Service, Gene/Cell therapy Date announced: 2016-06-23 Type: Placing To be raised: Up to L6.5 million ($9.5 million) Shares: 8.1 million Price…

    Published on 6/27/2016
  • Sernova proposes private placement of units

    Sernova Corp. (TSX-V:SVA; OTCQB:SEOVF), London, Ontario Business: Gene/Cell therapy, Transplant, Endocrine/Metabolic Date announced: 2016-06-21 Type: Private placement of units To be raised: C$2 million ($1.6 million) …

    Published on 6/27/2016
  • AC Immune amends IPO

    AC Immune S.A., Lausanne, Switzerland Business: Neurology Date announced: 2016-06-15 Type: IPO To be raised: TBD Shares: TBD Price: TBD Underwriters: Credit Suisse; Jefferies; Leerink Partners Note: AC Immune amended …

    Published on 6/20/2016
  • Gemphire amends IPO

    Gemphire Therapeutics Inc., Northville, Mich. Business: Cardiovascular, Endocrine/Metabolic Date announced: 2016-06-13 Type: IPO To be raised: Up to $48.8 million Shares: 3.8 million Price: $11-$13 Underwriters: …

    Published on 6/20/2016
  • AiVita Biomedical completes venture financing

    AiVita Biomedical Inc., Irvine, Calif. Business: Gene/Cell therapy, Dermatology, Cancer Date completed: 2016-06-10 Type: Venture financing Raised: $2 million Investor: California Technology Ventures

    Published on 6/20/2016
  • Allecra completes venture financing

    Allecra Therapeutics GmbH, Lorrach, Germany Business: Infectious Date completed: 2016-06-15 Type: Venture financing Raised: EUR22 million ($24.8 million) Investors: Delos Capital; Forbion Capital Partners; Edmond de …

    Published on 6/20/2016
  • Alpine Immune Sciences completes venture financing

    Alpine Immune Sciences Inc., Seattle, Wash. Business: Cancer, Autoimmune, Infectious Date completed: 2016-06-13 Type: Venture financing Raised: $48 million Investors: OrbiMed Advisors; Frazier & Co.; Alpine BioVentures

    Published on 6/20/2016
  • Antibe Therapeutics completes private placement of units

    Antibe Therapeutics Inc. (TSX-V:ATE; OTCQX:ATBPF), Hamilton, Ontario Business: Neurology, Autoimmune, Endocrine/Metabolic Date completed: 2016-06-10 Type: Private placement of units Raised: C$968,500 ($758,142) Units: 9…

    Published on 6/20/2016
  • BioTime completes follow-on

    BioTime Inc. (NYSE-M:BTX; Tel Aviv:BTX), Alameda, Calif. Business: Gene/Cell therapy, Pulmonary, Diagnostic Date completed: 2016-06-16 Type: Follow-on Raised: $17.5 million Shares: 7.3 million Price: $2.39 Shares after …

    Published on 6/20/2016
  • Blade Therapeutics completes venture financing

    Blade Therapeutics Inc., South San Francisco, Calif. Business: Pulmonary, Autoimmune Date completed: 2016-06-16 Type: Venture financing Raised: $45 million Investors: Deerfield Management; Pfizer Venture Investments; …

    Published on 6/20/2016
  • Celsion completes direct public offering

    Celsion Corp. (NASDAQ:CLSN; Tel Aviv:CLSN), Lawrenceville, N.J. Business: Drug delivery, Cancer, Cardiovascular Date completed: 2016-06-13 Type: Direct public offering Raised: $6 million Shares: 2.3 million Price: $1.36…

    Published on 6/20/2016
  • Champions Oncology completes follow-on

    Champions Oncology Inc. (NASDAQ:CSBR), Hackensack, N.J. Business: Cancer Date completed: 2016-06-09 Type: Follow-on Raised: $5.1 million Shares: 2.3 million Price: $2.25 Shares after offering: 11 million Underwriter: …

    Published on 6/20/2016
  • Cytori completes rights offering of units

    Cytori Therapeutics Inc. (NASDAQ:CYTX), San Diego, Calif. Business: Gene/Cell therapy, Autoimmune, Cardiovascular Date completed: 2016-06-15 Type: Rights offering of units Raised: $17.1 million Shares: 6.7 million Price…

    Published on 6/20/2016
  • GlycoMimetics completes follow-on

    GlycoMimetics Inc. (NASDAQ:GLYC), Rockville, Md. Business: Hematology, Cancer, Cardiovascular Date completed: 2016-06-17 Type: Follow-on Raised: $20.1 million Shares: 3.3 million Price: $6.10 Shares after offering: 22.7…

    Published on 6/20/2016
  • ImmunoGen completes private placement of senior convertible notes

    ImmunoGen Inc. (NASDAQ:IMGN), Waltham, Mass. Business: Cancer Date completed: 2016-06-15 Type: Private placement of senior convertible notes Raised: $100 million Shares outstanding prior: 87.1 million Investor: …

    Published on 6/20/2016
  • Innocoll completes follow-on

    Innocoll Holdings plc (NASDAQ:INNL), Athlone, Ireland Business: Drug delivery, Infectious, Neurology Date completed: 2016-06-16 Type: Follow-on Raised: $40.1 million Shares: 5.7 million Price: $7 Shares after offering: …

    Published on 6/20/2016

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993